Greetings, Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer With the overwhelming success of previous Personalized Medicine Conferences , Conference Series welcomes you to attend the 10 th World Congress on Precision and Personalized Medicine held on October 5-6, 2018 Osaka, Japan. Conference Series, the World Class Scientific Events Organizer is hosting this esteemed congress. The main theme of this event is “Current Trends and Future Directions of Personalized Medicine”. Submit your Abstract and register as soon as possible to reserve your slot. Abstract submission: https://personalized-medicine.conferenceseries.com/abstract-submissi...
Popular posts from this blog
Personalized Medicine Congress 2018 , we warmly invite you to participate at 10th World Congress on Precision and Personalized Medicine during October 05-06, 2018 Osaka, Japan. 10th World Congress on Precision and Personalized Medicine will provide an opportunity to hear and meet Researchers, Practitioners, and Business Professionals to share expertise, foster collaborations and assess rising innovations across the world. This will be equally informative for participants who attend this meeting as well as a for key opinion leaders who want to brush up on their knowledge outside their own area of specialization. This Conference will provide a forum for exchange of ideas and authoritative views by leading scientists as well as business leaders and investors in this exciting field. Outstanding keynote speakers and well known leading scientists and experts from around the globe will be expected to share their knowledge. When becoming our partner, we will do our out most to satisfy yo...
Precision Immunotherapy
Track 10: Precision Immunotherapy: Immunotherapy is a type of treatment that helps the body’s immune system fight cancer. Several kinds of immunotherapy, including immune checkpoint inhibitors, adoptive cell transfer, and therapeutic vaccines are either commercially available or in clinical development. To date, six immune checkpoint inhibitors have been approved by FDA for the treatment of eight types of cancer. One of the inhibitors has also been approved to treat any solid tumor that has a specific genetic feature. This was the first FDA approval of its kind and a major advance for precision cancer medicine , in which the molecular characteristics of a tumor are used to identify effective therapies. Immunotherapy Response, Resistance, and Toxicity Pediatric Immunotherapy Discovery Immuno-Oncology Validate Immunotherapy Biomarkers
Comments
Post a Comment